nifedipine has been researched along with galantamine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| de Los Ríos, C; Egea, J; Gálvez, E; García, AG; Iriepa, I; León, R; López, MG; Marco-Contelles, J; Moraleda, I; Romero, A; Samadi, A; Villarroya, M | 1 |
| Arce, MP; Conde, S; del Barrio, L; Egea, J; García, AG; González-Muñoz, GC; León, R; López, B; López, MG; Martín-de-Saavedra, MD; Pérez, C; Rodríguez-Franco, MI; Romero, A; Villarroya, M | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| LIEBMANN, H; MATTHIES, H | 1 |
| MATTHIES, H; SCHMIDT, J | 1 |
| Bastida, J; Berkov, S; Codina, C; Sidjimova, B; Viladomat, F | 1 |
| Katoch, D; Kumar, N; Kumar, S; Singh, B | 1 |
| Choi, YH; Gude, H; Lubbe, A; Verpoorte, R | 1 |
| Blunden, G; Cahlíková, L; Havelek, R; Koutová, D; Maafi, N; Opletal, L; Řezáčová, M | 1 |
2 review(s) available for nifedipine and galantamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chemical and Biological Aspects of Montanine-Type Alkaloids Isolated from Plants of the Amaryllidaceae Family.
Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Cell Line, Tumor; Cholinesterase Inhibitors; Galantamine; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Isoquinolines; Nootropic Agents; Phenanthridines; Plant Extracts; Secondary Metabolism | 2020 |
11 other study(ies) available for nifedipine and galantamine
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Calcium; Catalytic Domain; Cell Death; Cell Line, Tumor; Cholinesterase Inhibitors; Cytotoxins; Electron Transport Chain Complex Proteins; Electrophorus; Glucose; Hippocampus; Humans; Isomerism; Models, Molecular; Naphthyridines; Neuroprotective Agents; Okadaic Acid; Oligomycins; Oxygen; Peptide Fragments; Protein Binding; Protein Phosphatase 2; Rats; Rotenone; Structure-Activity Relationship | 2010 |
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antineoplastic Agents; Butyrylcholinesterase; Calcium; Cell Death; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Okadaic Acid; Peptide Fragments; Phenothiazines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The effect of Amaryllidaceae alkaloids galanthamine, narwedine, hemanthamine and tazettine on neuromuscular transmission].
Topics: Alkaloids; Amaryllidaceae Alkaloids; Galantamine; Humans; Neuromuscular Junction; Parasympathomimetics; Phenanthridines | 1961 |
[On the pharmacology of the Amaryllidaceae alkaloids galanthamine, narwedine, hemanthamine and tazettine].
Topics: Alkaloids; Amaryllidaceae Alkaloids; Galantamine; Phenanthridines | 1961 |
Alkaloid diversity in Galanthus elwesii and Galanthus nivalis.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Galantamine; Galanthus; Gas Chromatography-Mass Spectrometry; Phenanthridines | 2011 |
Simultaneous quantification of Amaryllidaceae alkaloids from Zephyranthes grandiflora by UPLC-DAD/ESI-MS/MS.
Topics: Amaryllidaceae Alkaloids; Calibration; Chromatography, High Pressure Liquid; Galantamine; Liliaceae; Phenanthridines; Plant Extracts; Pyrroles | 2012 |
Seasonal accumulation of major alkaloids in organs of pharmaceutical crop Narcissus Carlton.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Drug Discovery; Galantamine; Magnetic Resonance Spectroscopy; Molecular Structure; Multivariate Analysis; Narcissus; Phenanthridines; Plant Leaves; Plant Roots; Seasons; Time Factors | 2013 |